Epidiolex (also called Epidyolex) is a licensed cannabidiol (CBD) oil produced originally by the British company GW Pharmaceuticals Limited, now a subsidiary of Jazz Pharmaceuticals plc. This oral solution is licenced for drug-resistant epilepsy secondary to Dravet and Lennox-Gastaut syndromes, as well as tuberous sclerosis complex, when prescribed in combination with clobazam.
